Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2410 stock hub

HKG/2410 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2410is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.7B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2410
In the news

Latest news · HKG/2410

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/En/a
P25 10.7P50 17.9P75 38.5
ROE-80.6
P25 -14.7P50 2P75 9.4
ROIC-37
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2410 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
133
Groups with data
11
Currency
CNY
Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
China
Country code
HK
Employees
173
Employees Change
20%
Employees Change Percent
13.07
Enterprise value
HKD 3.5B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE100006L34
Last refreshed
2026-05-10
Market cap
HKD 3.7B
Price
HKD 9.67
Price currency
HKD
Sector
Healthcare
Sic
2836
Symbol
hkg/2410
Website
https://www.tykmedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-8.97%
EV Earnings
-10.44x
P/B ratio
11.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Net Income
HKD -333.6M
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Profit Per Employee
HKD -1.9M
ROA
-23.78
ROCE
-68.34
ROE
-80.61
ROIC
-37.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
-69.71%
EPS Growth Quarters
1
EPS Growth Years
1
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
HKD 867.7M
Cash
HKD 408.7M
Current Assets
HKD 507.9M
Current Liabilities
HKD 354.4M
Debt
HKD 170.1M
Debt Equity
HKD 0.53
Equity
HKD 318.9M
Interest Coverage
-21.62
Liabilities
HKD 548.8M
Long Term Assets
HKD 359.8M
Long Term Liabilities
HKD 194.3M
Net Cash
HKD 238.7M
Net Cash By Market Cap
HKD 6.42
Net Cash Growth
-24.38%
Net Debt Equity
HKD -0.75
Tangible Book Value
HKD 255.8M
Tangible Book Value Per Share
HKD 0.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.43
Net Working Capital
HKD -94.6M
Quick ratio
1.29
Working Capital
HKD 148.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-10.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-69.69%
200-day SMA
13.94
50-day SMA
10.74
50-day SMA vs 200-day SMA
50under200
All Time High
56.55
All Time High Change
-82.9%
All Time High Date
2024-12-23
All Time Low
9.2
All Time Low Change
5.11%
All Time Low Date
2026-05-05
ATR
0.45
Beta1y
2.23
Beta2y
1.49
Ch YTD
-26.24
High
9.86
High52
32.4
High52 Date
2025-05-13
High52ch
-71.13%
Low
9.5
Low52
9.2
Low52 Date
2026-05-05
Low52ch
5.11%
Ma50ch
-9.96%
Price vs 200-day SMA
-30.62%
RSI
34.87
RSI Monthly
42.33
RSI Weekly
34.76
Sharpe ratio
-1.02x
Sortino ratio
-1.46
Total Return
-10.94%
Tr YTD
-26.24
Tr1m
-12.09%
Tr1w
0.73%
Tr3m
-25.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
HKD -358.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
235,924,654%
Shares Insiders
2.08%
Shares Institutions
25.6%
Shares Out
384,673,818
Shares Qo Q
2%
Shares Yo Y
10.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

36
MetricValue
Average Volume
1,979,375x
Bv Per Share
0.84
Ch1m
-12.09
Ch1w
0.73
Ch1y
-69.69
Ch3m
-25.04
Ch6m
-32.09
Change
0.73%
Change From Open
1.04
Close
9.6
Days Gap
-0.31
Depreciation Amortization
17,193,987.9
Dollar Volume
27,632,025
Earnings Date
2026-06-01
EBIT
HKD -358.9M
EBITDA
HKD -342.3M
EPS
HKD -0.89
F Score
0
Fiscal Year End
December
Founded
2,017
Is Primary Listing
1
Last Earnings Date
2026-03-30
Last Report Date
2025-12-31
Ma150
12.85
Ma150ch
-24.75%
Ma20
10.31
Ma20ch
-6.22%
Next Earnings Date
2026-06-01
Open
9.57
Position In Range
47.22
Ppne
267,115,413.8
Price Date
2026-05-08
Ptbv Ratio
14.54
Relative Volume
1.48x
Tr6m
-32.09%
Volume
2,857,500
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2410 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2410 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-69.7%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HKG/2410?

Insider, institutional, and short-interest positioning.

Institutional ownership
+25.6%
Share of float held by funds and institutions
Insider ownership
+2.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+10.9%
Negative means the company is buying back shares.
Technical

HKG/2410 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
34.9
Neutral momentum band
Price vs 200-day MA
-30.6%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-1.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2410

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2410 stock rating?

hkg/2410 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2410 analysis?

The full report lives at /stocks/hkg/2410/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2410?

The latest report frames hkg/2410 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2410 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

hkg/2410 stock profile: metrics, valuation and analysis | เอเจนต์ AI ตลาดหุ้น